Results 101 to 110 of about 1,607 (132)

Central nervous system infection by Bacillus cereus: a case report and literature review. [PDF]

Rev Neurol, 2022
Rollán-Martínez Herrera M, González-Urdiales P, Zubizarreta-Zamalloa A, Rodríguez-Merino E, Martínez-Dubarbie F.   +4 more
europepmc   +1 more source

[Plasmid-mediated colistin resistance in pathogenic bacteria]. [PDF]

Rev Med Inst Mex Seguro Soc
Casillas-Vega N, Mendoza-Olazarán S.
europepmc   +1 more source

Clinical and microbiological characteristics of neonates with bacteremia by NDM-producing Klebsiella pneumoniae in a Peruvian referral hospital. [PDF]

Rev Peru Med Exp Salud Publica
Lara-Herrera F, Amable-Castilla A, Mori-Rodriguez D, Pérez-Lazo G.   +3 more
europepmc   +1 more source

Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú [PDF]

Biomedica, 2022
Matta-Chuquisapon J, Valencia-Bazalar E, Sevilla-Andrade C, Barrón-Pastor HJ.   +3 more
europepmc   +1 more source

Multidrug-resistant enterobacterales carrying the acc(6')-Ian gene. [PDF]

Rev Peru Med Exp Salud Publica
Soto-Flores KG, Cisneros-Aguilar JR, Rueda-Vicente MK, Gonzales-Escalante E, Gonzales-Rodríguez AO, Gomez de La Torre-Prettel JC, Alvarado Ríos LA.   +6 more
europepmc   +1 more source

The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19. [PDF]

Vacunas, 2023
AliMohammadi A, Chezani-Sharahi N, Hezaveh ZA, Abbasi E, Shariati A, Ghaznavi-Rad E.   +5 more
europepmc   +1 more source

Características clínico microbiológicas de la infección por Acinetobacter baumannii en pacientes con afecciones hematológicas

Revista Cubana de Medicina, 2018
Aliette García García, José Carnot Uria, Marcia Hart Cáceres, Calixto Hernández Cruz, Jorge Muñío Perurena, Kali Cepero Llauger, Ibis K Pardo Ramírez, Sheila M Pino Linares   +7 more
doaj  

[In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug]. [PDF]

Rev Esp Quimioter
García-Rivera C, Navarro M, Parra M, Sánchez Bautista A, Gómez I, Ventero MP, Rodríguez JC.   +6 more
europepmc   +1 more source

[Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city]. [PDF]

Rev Esp Quimioter, 2021
Soria-Segarra C, Delgado-Valverde M, Serrano-García ML, López-Hernández I, Navarro-Marí JM, Gutiérrez-Fernández J.   +5 more
europepmc   +1 more source

Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals. [PDF]

Rev Esp Quimioter
Garnacho-Montero J, Aguado JM, Alemparte E, Horcajada JP, López-Medrano F, Ramírez P, Giró-Perafita A, Blasco M, Suberviola B.   +8 more
europepmc   +1 more source